Navigation Links
Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
Date:9/4/2012

LONDON, September 4, 2012 /PRNewswire/ --

Pharma IQ recently launched its 2012 Pharmaceutical Co-Crystals and Amorphous Materials Summit programmes, featuring a brand new Solid Form Co-Crystals and Amorphous Focus Morning. This Focus Morning is aim to discovery the overlapping and discuss crucial areas that are involved in both, as well as to give participants as much input and expertise from across both areas in one space.

The Solid Form Co-Crystals and Amorphous Focus Morning features case studies and interactive sessions on the effective characterisation of co-crystals and amorphous. From the discriminatory analysis on dissolution behaviour of several disordered/amorphous forms to amorphous fractions in crystalline materials. These topics will help participants to understand structure and dynamics in pharmaceutical solids.

Four professors from UK's leading labs will lead roundtable discussions which will cover pressing questions about the future application of co-crystals and amorphous techniques both in pharmaceuticals and outside, the latest developments affecting bioavailability and the FDA policy of solid form.

In addition to the Focus Morning, the 2012 summit programme will assess the clinical application of co-crystals and amorphous forms into the manufacturing scale up process, focus on developing and forming effective co-crystals and amorphous designs throughout the phases of development and utilise novel methods of formulation identification to improve drug efficacy, reduce cost of development and expedite time to market.

With the release of the new FDA draft guidance on classification of solid form and the regulatory implications of this classification, it is crucial to learn the newest and most innovative developments in characterisation, predictability, processing as well as the legal and regulatory challenges.

Taking place from 25th to 26th September, Pharmaceutical Co-Crystals and Amorphous Materials summits will be co-located at the Ramada Apollo Amsterdam, Netherlands willoffer unparalleled knowledge and networking opportunities for researchers, pharmacist specialists and formulation scientists to discuss practical approaches and give participants take way top tips for future drug development in the solid state field.

Further information about Pharmaceutical Co-Crystals 2012 Summit is available on the summit website at bit.ly/OgGOab. For information about the Pharmaceutical Amorphous Materials summit, please visit bit.ly/OQH4Q2. Visitors can also access the online resources centre for the latest news and developments of co-crystals and amorphous materials techniques.


'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAZOO Prepares For First Three National Direct Response Campaigns and Distribution of PAZOO Branded Products
2. Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management
3. Optimal Radiology Unveils New Brand
4. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
5. OTC Consumer Brand Loyalty Falters in Wake of Branded Recalls, Change in FSA Law, and Recession - Finds Kline
6. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
7. Ancor and Merit acquire Uplift Technologies for Carex Health Brands
8. Education, Reimbursement Options are Key Components of Effective Pharmaceutical Brand Websites
9. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
10. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
11. Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
Breaking Medicine News(10 mins):